April Wilkerson crafts a stylish live edge end table that's easy to build.

With immunology and inflammation blockbusters like AbbVie’s Skyrizi and Rinvoq reeling in nearly $7 billion combined in the ...

Recent drug trial disappointments and leadership changes have challenged Vertex, yet its cystic fibrosis dominance and strong pipeline keep it in the game for long-term investors. Over the past year ...

Abstract: The adaptive estimation of coexisting temporal vertex (node) and edge signals on graphs is a critical task when a change in edge signals influences the temporal dynamics of the vertex ...

The stock has climbed 15.66% year-to-date, recovering from last year's volatility. With selling pressure creeping in, the question is whether this rally has legs, or if it’s time for a reset. Wall ...

All products featured on WIRED are independently selected by our editors. However, we may receive compensation from retailers and/or from purchases of products through these links. Learn more. Much of ...

These are independent reviews of the products mentioned, but TIME receives a commission when purchases are made through affiliate links at no additional cost to the purchaser. Combing through ...